Review
Copyright ©2010 Baishideng Publishing Group Co.
World J Radiol. Nov 28, 2010; 2(11): 427-433
Published online Nov 28, 2010. doi: 10.4329/wjr.v2.i11.427
Table 1 General characteristics of currently marketed gadolinium chelates used for magnetic resonance imaging[6]
NameAcronymGd-DTPAGd-EOB-DTPAGd-BOPTAMS325Gd-DTPA-BMAGd-DTPA-BMEAGd-HP-DO3AGd-BT-DO3AGd-DOTA
Generic nameGadopentetate dimeglumineGadoxetic acid, disodium saltGadobenate dimeglumineGadofosveset, trisodium saltGadodiamideGadoversetamideGadoteridolGadobutrolGadoterate meglumine
Trade nameMagnevistâPrimovist®MultiHanceâVasovist®OmniscanâOptiMARKâProHanceâGadovistâDotaremâ
CompanyBayer-ScheringBayer-ScheringBraccoEPIXGE-HealthcareMallinckrodtBraccoBayer-ScheringGuerbet
Chemical structureOpen-chainOpen-chainOpen-chainOpen-chainOpen-chainOpen-chainMacrocyclicMacrocyclicMacrocyclic
ChargeIonicIonicIonicIonicNonionicNonionicNonionicNonionicIonic
Concentration (M)0.50.250.50.250.50.50.510.5
Osmolality at 37°C (mOsm/kg H2O)19606881970825789111063016031350
Viscosity (mPa.s) at 37°C2.91.195.32.061.421.34.962
FormulationFree DTPA (1 mmol/L)Ca-EOB-DTPA (trisodium salt) (1.5 mmol/L)No formulationFosveset (0.325 mmol/L)Ca-DTPA-BMA (caldiamide) (Na+ salt) (25 mmol/L)Ca-DTPA-BMEA (Na+ salt) (50 mmol/L)[Ca-HP-DO3A]2 (Ca2+ salt) (0.5 mmol/L)Ca-BT-DO3A (Na+ salt) (1.0 mmol/L)No formulation
Hydrophilicity (log P Butanol/water)-3.16-2.11-2.33-2.11-2.13N/A-1.98-2-2.87
log Ktherm22.123.522.622.0616.916.623.821.825.6
log Kcond17.718.718.418.914.91517.114.719.3
Kinetic StabilityaLowMediumMediumMediumLowLowHighHighHigh
Table 2 Dissociation half life (T1/2) of gadolinium contrast agent under the same laboratory conditions[6]
Gd-CAT1/2, pH 1.2T1/2, pH 1T1/2, pH 1T1/2, pH 1 (Temp 250)
Temperature (°C)370370250
Dotaremâ (Guerbet, France)85 h23 h338 h338 h
Gadovistâ (Bayer Schering Pharma AG, Germany)18 h7 h43 h43 h
ProHanceâ (Bracco, Italy)4 h1.6 h3.9 h3.9 h
All linear chelatesNDND< 5 s< 5 s